HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

9-O-methanoprostaglandin I

shows weak inhibitory activity in rabbit platelet aggregation induced by ADP; RN given refers to cpd without isomeric designation
Also Known As:
9-O-methano-6 beta-PGI1; 9-O-methano-PGI1; 9-O-methanoprostaglandin I, 3aR-(3aalpha,5beta,6alpha(1E,3S*),6aalpha)-isomer; 9-O-methanoprostaglandin I, 3aS-(3aalpha,5beta,6alpha(1Z,3R*),6aalpha)-isomer; TEI 7165; TEI-7165; isocarbacyclin
Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Araki, Hiroaki: 2 articles (04/2003 - 08/2002)
2. Karasawa, Yasuko: 2 articles (04/2003 - 08/2002)
3. Komiyama, Hiroko: 2 articles (04/2003 - 08/2002)
4. Nakaike, Shiro: 2 articles (04/2003 - 08/2002)
5. Yoshida, Shigeru: 2 articles (04/2003 - 08/2002)
6. Abu Deiab, Ghina'a I: 1 article (01/2019)
7. Croatt, Mitchell P: 1 article (01/2019)
8. Hino, Noriko: 1 article (04/2003)
9. Katsuura, Yasuhiro: 1 article (04/2003)
10. Hitomi, Takehiko: 1 article (08/2002)

Related Diseases

1. Ischemia
2. Stroke (Strokes)
3. Infarction (Infarctions)
4. Brain Ischemia (Cerebral Ischemia)
5. Cerebral Infarction

Related Drugs and Biologics

1. Epoprostenol (Prostacyclin)
2. Valerates
3. Lipids
4. TTC 909
5. TEI 9090 (clinprost)
6. 9-O-methanoprostaglandin I
7. Neuroprotective Agents

Related Therapies and Procedures

1. Microspheres (Microsphere)